V. Conde

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

A. Carrato, J. Tabernero, M. Valladares-Ayerbes, 2019, British Journal of Cancer.

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

A. Carrato, R. Salazar, C. García-Girón, 2021, Drugs & Aging.

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

A. Carrato, R. Salazar, A. Abad, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of miniDOX (reduced dose docetaxel–oxaliplatin–capecitabine) in “suboptimal” patients with advanced gastric cancer (AGC). TTD 08-02

M. Alsina, B. Massuti, M. Valladares-Ayerbes, 2013, Cancer Chemotherapy and Pharmacology.

Unusual long survival in a case of heterotaxy and polysplenia

C. Mesas, K. Doello, V. Conde, 2020, Surgical and Radiologic Anatomy.

Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy

Igor Zwir, I. Zwir, J. Marchal, 2020, Cancers.

The impact of PKR activation: from neurodegeneration to cancer

J. Marchal, M. Perán, C. Rivas, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer

M. Ruíz-Borrego, F. Carabantes, J. Cruz, 2021, Scientific Reports.

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice

M. Fontanillas, F. Carabantes, J. Illarramendi, 2018, Clinical and Translational Oncology.

Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism

H. Boulaiz, J. Marchal, E. Carrillo, 2017, Expert Reviews in Molecular Medicine.